Sensing and Detection

Clinical Cardiac Pacing, Defibrillation, and Resynchronization Therapy

Volumn , Issue , 2007, Pages 75-160

  Swerdlow, Charles D ^a,b   Gillberg, Jeffrey M ^c   Olson, Walter H ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

^c MEDTRONIC INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882891721     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-2536-8.50008-X     Document Type: Chapter

References (179)

1. Parsonnet V, Myers GH, Kresh YM Characteristics of intracardiac electrograms II: Atrial endocardial electrograms. PACE 1980, 3:406-417.
2. Saxonhouse SJ, Conti JB, Curtis AB Current of injury predicts adequate active lead fixation in permanent pacemaker/defibrillation leads. J Am Coll Cardiol 2005, 45:412-417.
3. Sweeney MO, Ellison KE, Shea JB, et al. Provoked and spontaneous high-frequency, low-amplitude, respirophasic noise transients in patients with implantable cardioverter defibrillators. J Cardiovasc Electrophysiol 2001, 12:402-410.
4. Weretka S, Michaelsen J, Becker R, et al. Ventricular oversensing: A study of 101 patients implanted with dual chamber defibrillators and two different lead systems. PACE 2003, 26(1 Pt 1):65-70.
5. Platia EV, Brinker JA Time course of transvenous pacemaker stimulation impedance, capture threshold, and electrogram amplitude. PACE 1986, 9:620-625.
6. DeCaprio V, Hurzeler P, Furman S A comparison of unipolar and bipolar electrograms for cardiac pacemaker sensing. Circulation 1977, 56:750-755.
7. Cornacchia D, Jacopi F, Fabbri M, et al. [Comparison between active screw type and passive electrodes in permanent intra-ventricular pacing]. Minerva Cardioangiol 1984, 32:101-103.
8. Ceviz N, Celiker A, Kucukosmanoglu O, et al. Comparison of mid-term clinical experience with steroid-eluting active and passive fixation ventricular electrodes in children. PACE 2000, 23:1245-1249.
9. Danilovic D, Ohm OJ Pacing impedance variability in tined steroid eluting leads. PACE 1998, 21:1356-1363.
10. Hua W, Mond HG, Strathmore N Chronic steroid-eluting lead performance: A comparison of atrial and ventricular pacing. PACE 1997, 20(1 Pt 1):17-24.
11. Crossley GH, Brinker JA, Reynolds D, et al. Steroid elution improves the stimulation threshold in an active-fixation atrial permanent pacing lead: A randomized, controlled study. Model 4068 Investigators. Circulation 1995, 92:2935-2939.
12. Wish M, Swartz J, Cohen A, et al. Steroid-tipped leads versus porous platinum permanent pacemaker leads: A controlled study. PACE 1990, 13(12 Pt 2):1887-1890.
13. Ellenbogen KA, Wood MA, Gilligan DM Evaluation of "inappropriate" ICD shocks in an asymptomatic patient following myocardial infarction. PACE 1996, 19:254-255.
14. Goldschlager N, Epstein A, Friedman P, et al. Environmental and drug effects on patients with pacemakers and implantable cardioverter/defibrillators: A practical guide to patient treatment. Arch Intern Med 2001, 161:649-655.
15. Rajawat YS, Patel VV, Gerstenfeld EP, et al. Advantages and pitfalls of combining device-based and pharmacologic therapies for the treatment of ventricular arrhythmias. PACE 2004, 27:1670-1681.
16. Theres H, Stadler RW, Stylos L, et al. Comparison of electrocardiogram and intrathoracic electrogram signals for detection of ischemic ST segment changes during normal sinus and ventricular paced rhythms. J Cardiovasc Electrophysiol 2002, 13:990-995.
17. Centurion OA, Isomoto S, Shimizu A, et al. The effects of aging on atrial endocardial electrograms in patients with paroxysmal atrial fibrillation. Clin Cardiol 2003, 26:435-438.
18. Frohlig G, Schwerdt H, Schieffer H, et al. Atrial signal variations and pacemaker malsensing during exercise: A study in the time and frequency domain. J Am Coll Cardiol 1988, 11:806-813.
19. Ross BA, Zeigler V, Zinner A, et al. The effect of exercise on the atrial electrogram voltage in young patients. PACE 1991, 14:2092-2097.
20. Schuchert A, Kuck KH, Bleifeld W Stability of pacing threshold, impedance, and R wave amplitude at rest and during exercise. PACE 1990, 13(12 Pt 1):1602-1608.
21. Shandling AH, Florio J, Castellanet MJ, et al. Physical determinants of the endocardial P wave. PACE 1990, 13(12 Pt 1):1585-1589.
22. Rosenheck S, Schmaltz S, Kadish AH, et al. Effect of rate augmentation and isoproterenol on the amplitude of atrial and ventricular electrograms. Am J Cardiol 1990, 66:101-102.
23. Varriale P, Chryssos BE Atrial sensing performance of the single-lead VDD pacemaker during exercise. J Am Coll Cardiol 1993, 22:1854-1857.
24. Chan CC, Lau CP, Leung SK, et al. Comparative evaluation of bipolar atrial electrogram amplitude during everyday activities: Atrial active fixation versus two types of single pass VDD/R leads. PACE 1994, 17(11 Pt 2):1873-1877.
25. Furman S, Hurzeler P, De Caprio V Cardiac pacing and pacemaker. III. Sensing the cardiac electrogram. Am Heart J 1997, 93:794-801.
26. Ellenbogen KA, Wood MA, Stambler BS, et al. Measurement of ventricular electrogram amplitude during intraoperative induction of ventricular tachyarrhythmias. Am J Cardiol 1992, 70:1017-1022.
27. Taneja T, Goldberger J, Parker MA, et al. Reproducibility of ventricular fibrillation characteristics in patients undergoing implantable cardioverter defibrillator implantation. J Cardiovasc Electrophysiol 1997, 8:1209-1217.
28. McAlister HF, Klementowicz PT, Calderon EM, et al. Atrial electrogram analysis: Antegrade versus retrograde. PACE 1988, 11(11 Pt 2):1703-1707.
29. Wainwright R, Davies W, Tooley M Ideal atrial lead positioning to detect retrograde atrial depolarization by digitization and slope analysis of the atrial electrogram. PACE 1984, 7(6 Pt 2):1152-1158.
30. Timmis GC, Westveer DC, Bakalyar DM, et al. Discrimination of anterograde from retrograde atrial electrograms for physiologic pacing. PACE 1988, 11:130-140.
31. Davies DW, Wainwright RJ, Tooley MA, et al. Detection of pathological tachycardia by analysis of electrogram morphology. PACE 1986, 9:200-208.
32. Roithinger FX, SippensGroenewegen A, Karch MR, et al. Organized activation during atrial fibrillation in man: Endocardial and electrocardiographic manifestations. J Cardiovasc Electro-physiol 1998, 9:451-461.
33. Konings KT, Smeets JL, Penn OC, et al. Configuration of unipolar atrial electrograms during electrically induced atrial fibrillation in humans. Circulation 1997, 95:1231-1241.
34. Wood M, Moskovljevic P, Stambler B, et al. Comparison of bipolar atrial electrogram amplitude in sinus rhythm, atrial fibrillation, and atrial flutter. PACE 1996, 19:150-156.
35. Lewalter T, Schimpf R, Kulik D, et al. Comparison of spontaneous atrial fibrillation electrogram potentials with the P-wave electrogram amplitude in dual chamber pacing with unipolar atrial sensing. Europace 2000, 2:136-140.
36. Ropella KM, Sahakian AV, Baerman JM, et al. The coherence spectrum: A quantitative discriminator of fibrillatory and nonfibrillatory cardiac rhythms. Circulation 1989, 80:112-119.
37. Baerman JM, Ropella KM, Sahakian AV, et al. Effect of bipole configuration on atrial electrograms during atrial fibrillation. PACE 1990, 13:78-87.
38. Karagueuzian HS, Khan SS, Peters W, et al. Nonhomogeneous local atrial activity during acute atrial fibrillation: Spectral and dynamic analysis. PACE 1990, 13(12 Pt 2):1937-1942.
39. Ropella KM, Sahakian AV, Baerman JM, et al. Effects of procainamide on intra-atrial [corrected] electrograms during atrial fibrillation: Implications [corrected] for detection algorithms. Circulation 1988, 77:1047-1054.
40. Beeman AL, Deutsch G, Rea RF Paradoxical undersensing due to quiet timer blanking. Heart Rhythm 2004, 1:345-347.
41. Willems R, Holemans P, Ector H, et al. Paradoxical undersensing at a high sensitivity in dual chamber pacemakers. PACE 2001, 24:308-315.
42. Castro A, Liebold A, Vincente J, et al. Evaluation of autosensing as an automatic means of maintaining a 2:1 sensing safety margin in an implanted pacemaker. Autosensing Investigation Team. PACE 1996, 19(11 Pt 2):1708-1713.
43. Nowak B, Kampmann C, Schmid FX, et al. Pacemaker therapy in premature children with high degree AV block. PACE 1998, 21:2695-2698.
44. Inama G, Santini M, Padeletti L, et al. Far-field R wave over-sensing in dual chamber pacemakers designed for atrial arrhythmia management: Effect of pacing site and lead tip to ring distance. PACE 2004, 27:1221-1230.
45. Callans DJ, Hook BG, Kleiman RB, et al. Unique sensing errors in third-generation implantable cardioverter-defibrillators. J Am Coll Cardiol 1993, 22:1135-1140.
46. Callans DJ, Hook BG, Marchlinski FE Paced beats following single nonsensed complexes in a "codependent" cardioverter defibrillator and bradycardia pacing system: Potential for ventricular tachycardia induction. PACE 1991, 14:1281-1287.
47. Callans DJ, Hook BG, Marchlinski FE Effect of rate and coupling interval on endocardial R wave amplitude variability in permanent ventricular sensing lead systems. J Am Coll Cardiol 1993, 22:746-750.
48. Dekker LR, Schrama TA, Steinmetz FH, et al. Undersensing of VF in a patient with optimal R wave sensing during sinus rhythm. PACE 2004, 27(6 Pt 1):833-834.
49. Glikson M, Beeman AL, Luria DM, et al. Impaired detection of ventricular tachyarrhythmias by a rate-smoothing algorithm in dual-chamber implantable defibrillators: Intradevice interactions. J Cardiovasc Electrophysiol 2002, 13:312-318.
50. Cooper JM, Sauer W, Verdino R Absent ventricular tachycardia detection in a biventricular implantable cardioverter-defibrillator due to intradevice interaction with a rate smoothing pacing algorithm. Heart Rhythm 2004, 1:728-731.
51. Shivkumar K, Feliciano Z, Boyle NG, et al. Intradevice interaction in a dual chamber implantable cardioverter defibrillator preventing ventricular tachyarrhythmia detection. J Cardiovasc Electrophysiol 2000, 11:1285-1288.
52. Ellenbogen KA, Wood MA, Kapadia K, et al. Short-term reproducibility over time of right ventricular pulse pressure as a potential hemodynamic sensor for ventricular tachyarrhythmias. PACE 1992, 15:971-974.
53. Leitch J, Klein G, Yee R, et al. Feasibility of an implantable arrhythmia monitor. PACE 1992, 15:2232-2235.
54. Swerdlow CD Implantation of cardioverter defibrillators without induction of ventricular fibrillation. Circulation 2001, 103:2159-2164.
55. Tung L, Tovar O, Neunlist M, et al. Effects of strong electrical shock on cardiac muscle tissue. Ann N Y Acad Sci 1994, 720:160-175.
56. Winkle RA, Bach SM, Echt DS, et al. The automatic implantable defibrillator: Local ventricular bipolar sensing to detect ventricular tachycardia and fibrillation. Am J Cardiol 1983, 52:265-270.
57. Goldberger JJ, Horvath G, Donovan D, et al. Detection of ventricular fibrillation by transvenous defibrillating leads: Integrated versus dedicated bipolar sensing. J Cardiovasc Electrophysiol 1998, 9:677-688.
58. Yee R, Jones D, Jarvis E, et al. Changes in pacing threshold and R wave amplitude after transvenous catheter countershock. J Am Coll Cardiol 1984, 4:543-549.
59. Jung W, Manz M, Moosdorf R, et al. Changes in the amplitude of endocardial electrograms following defibrillator discharge: Comparison of two lead systems. PACE 1995, 18(12 Pt 1):2163-2172.
60. Swerdlow CD, Brown ML, Lurie K, et al. Discrimination of ventricular tachycardia from supraventricular tachycardia by a downloaded wavelet-transform morphology algorithm: A paradigm for development of implantable cardioverter defibrillator detection algorithms. J Cardiovasc Electrophysiol 2002, 13:432-441.
61. Kuhlkamp V, Dornberger V, Mewis C, et al. Clinical experience with the new detection algorithms for atrial fibrillation of a defibrillator with dual chamber sensing and pacing. J Cardiovasc Electrophysiol 1999, 10:905-915.
62. Wilkoff BL, Kuhlkamp V, Volosin K, et al. Critical analysis of dual-chamber implantable cardioverter-defibrillator arrhythmia detection: Results and technical considerations. Circulation 2001, 103:381-386.
63. Swerdlow CD Supraventricular tachycardia-ventricular tachycardia discrimination algorithms in implantable cardioverter defibrillators: State-of-the-art review. J Cardiovasc Electrophysiol 2001, 12:606-612.
64. Gunderson B, Patel A, Bounds C Automatic identification of implantable cardioverter-defibrillator lead problems using intra-cardiac electrograms. Comput Cardiol 2002, 29:121-124.
65. Swerdlow C, Shivkumar K Implantable cardioverter defibrillators: Clinical aspects. Cardiac Electrophysiology: From Cell to Bedside 2004, 980-993. WB Saunders, Philadephia. 4th ed. D.P. Zipes, J. Jalife (Eds.).
66. Garcia-Moran E, Mont L, Brugada J Inappropriate tachycardia detection by a biventricular implantable cardioverter defibrillator. PACE 2002, 25:123-124.
67. Lloyd M, Hayes D, Friedman P Troubleshooting. Cardiac Pacing and Defibrillation: A Clinical Approach 2000, 347-452. Futura, Armonk, NY. D. Hayes, M. Lloyd, P. Friedman (Eds.).
68. Ellenbogen KA, Wood MA, Shepard RK, et al. Detection and management of an implantable cardioverter defibrillator lead failure: Incidence and clinical implications. J Am Coll Cardiol 2003, 41:73-80.
69. Swerdlow C, Friedman P Advanced ICD troubleshooting: Part I. PACE 2005, 28:1322-1346.
70. Pinski SL 2:1 Tracking of sinus rhythm in a patient with a dual-chamber implantable cardioverter defibrillator: What is the mechanism?. J Cardiovasc Electrophysiol 2001, 12:503-504.
71. Hsu SS, Mohib S, Schroeder A, et al. T wave oversensing in implantable cardioverter defibrillators. J Interv Card Electrophysiol 2004, 11:67-72.
72. Sweeney MO, Hellkamp AS, Ellenbogen KA, et al. Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction. Circulation 2003, 107:2932-2937.
73. Wilkoff BL, Cook JR, Epstein AE, et al. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial [see comment]. JAMA 2002, 288:3115-3123.
74. Pinski S, Egula L, Sgarbossa E, et al. Incidence and causes of commlted shocks in noncommited implantable defibrillators [abstract]. J Am Coll Cardiol 2002, 39:93A.
75. Sweesy MW, Holland JL, Smith KW Electromagnetic interference in cardiac rhythm management devices. AACN Clin Issues 2004, 15:391-403.
76. Lau CP, Leung SK, Tse HF, et al. Automatic mode switching of implantable pacemakers: II. Clinical performance of current algorithms and their programming. PACE 2002, 25:1094-1113.
77. Israel CW Analysis of mode switching algorithms in dual chamber pacemakers. PACE 2002, 25:380-393.
78. Lam CT, Lau CP, Leung SK, et al. Improved efficacy of mode switching during atrial fibrillation using automatic atrial sensitivity adjustment. PACE 1999, 22(1 Pt 1):17-25.
79. Leung SK, Lau CP, Lam C, et al. Programmed atrial sensitivity: A critical determinant in atrial fibrillation detection and optimal automatic mode switching. PACE 1998, 21(11 Pt 2):2214-2219.
80. Pollak WM, Simmons JD, Interian A, et al. Pacemaker diagnostics: A critical appraisal of current technology. PACE 2003, 26(1 Pt 1):76-98.
81. Passman RS, Weinberg KM, Freher M, et al. Accuracy of mode switch algorithms for detection of atrial tachyarrhythmias. J Cardiovasc Electrophysiol 2004, 15:773-777.
82. Hammel E, Hudelo C, Mailland L, et al. Appropriate detection of Guidant pacemaker stored electrograms assessed by centralized arrhythmia workstation [abstract]. PACE 2000, 23:680.
83. Israel CW, Gascon D, Nowak B, et al. Diagnostic value of stored electrograms in single-lead VDD systems. PACE 2000, 23(11 Pt 2):1801-1803.
84. Melzer C, Sowelam S, Sheldon TJ, et al. Reduction of right ventricular pacing in patients with sinus node dysfunction using an enhanced search AV algorithm. PACE 2005, 28:521-527.
85. Sweeney M, Nsah E, McGrew F, et al. Reduction in ventricular pacing and its long term clinical outcomes: Preliminary results of the Save Pace Trial [abstract]. Heart Rhythm 2005, 2(Suppl):S322.
86. Olshansky B, Day J, McGuire M, et al. Inhibition of unnecessary RV pacing with AV search hysteresis in ICDs (INTRINSIC RV): Design and clinical protocol. PACE 2005, 28:62-66.
87. Deering T, Wilensky M, Tondato F, et al. Auto intrinsic conduction search algorithm: A prospective analysis [abstract 606]. PACE 2003, 26:1080.
88. Savoure A, Frohlig G, Galley D, et al. A new dual-chamber pacing mode to minimize ventricular pacing. PACE 2005, 28(Suppl 1):S43-S46.
89. Sweeney MO, Shea JB, Fox V, et al. Randomized pilot study of a new atrial-based minimal ventricular pacing mode in dual-chamber implantable cardioverter-defibrillators. Heart Rhythm 2004, 1:160-167.
90. de Voogt WG, Vonk BF, Albers BA, et al. Understanding capture detection. Europace 2004, 6:561-569.
91. Splett V, Trusty JM, Hayes DL, et al. Determination of pacing capture in implantable defibrillators: Benefit of evoked response detection using RV coil to can vector. PACE 2000, 23(11 Pt 1):1645-1650.
92. Schuchert A, Frese J, Stammwitz E, et al. Low settings of the ventricular pacing output in patients dependent on a pacemaker: Are they really safe?. Am Heart J 2002, 143:1009-1011.
93. Sperzel J, Binner L, Boriani G, et al. Evaluation of the atrial evoked response for capture detection with high-polarization leads. PACE 2005, 28(Suppl 1):S57-S62.
94. Sperzel J, Compton S, et al. Automatic measurement of atrial pacing thresholds in dual chamber pacemakers: Atrial Capture Management [abstract]. Heart Rhythm 2004, 1:S118.
95. Olson W Safety margins for sensing and detection: Programming tradeoffs. Implantable Cardioverter Defibrillator Therapy: The Engineering-Clinical Interface 1996, 389-420. Kluwer Academic Publishers, Norwell, MA. M. Kroll, M. Lehmann (Eds.).
96. Anderson MH, Murgatroyd FD, Hnatkova K, et al. Performance of basic ventricular tachycardia detection algorithms in implantable cardioverter defibrillators: Implications for device programming. PACE 1997, 20(12 Pt 1):2975-2983.
97. Murgatroyd F, Anderson M, Hnatkova K, et al. Comparison of misdiagnosis of atrial fibrillation as ventricular tachycardia by algorithms employed in current implantable cardioverter-defibrillators. Circulation 1993, 88:I-353.
98. Grimm W, Menz V, Hoffmann J, et al. Failure of third-generation implantable cardioverter defibrillators to abort shock therapy for nonsustained ventricular tachycardia due to shortcomings of the VF confirmation algorithm. PACE 1998, 21(4 Pt 1):722-727.
99. Raedle-Hurst TM, Wiecha J, Schwab JO, et al. Clinical performance of a specific algorithm to reconfirm self-terminating ventricular arrhythmias in current implantable cardioverter-defibrillators. Am J Cardiol 2001, 88:744-749.
100. Gillberg J, Olson W Dual-chamber sensing and detection for implantable cardioverter-defibrillators. Interventional Electrophysiology 2001, Lippincott Williams & Wilkins, Philadelphia. I. Singer (Ed.).
101. Arenal A, Almendral J, Villacastin J, et al. First postpacing interval variability during right ventricular stimulation: A single algorithm for the differential diagnosis of regular tachycardias. Circulation 1998, 98:671-677.
102. Glikson M, Swerdlow CD, Gurevitz OT, et al. Optimal combination of discriminators for differentiating ventricular from supraventricular tachycardia by dual-chamber defibrillators. J Cardiovasc Electrophysiol 2005, 16:732-739.
103. Brugada J, Mont L, Figueiredo M, et al. Enhanced detection criteria in implantable defibrillators. J Cardiovasc Electrophysiol 1998, 9:261-268.
104. Le Franc P, Kus T, Vinet A, et al. Underdetection of ventricular tachycardia using a 40 ms stability criterion: Effect of antiarrythmic therapy. PACE 1997, 20:2882-2892.
105. Neuzner J, Pitschner HF, Schlepper M Programmable VT detection enhancements in implantable cardioverter defibrillator therapy. PACE 1995, 18(3 Pt 2):539-547.
106. Swerdlow CD, Ahern T, Chen PS, et al. Underdetection of ventricular tachycardia by algorithms to enhance specificity in a tiered-therapy cardioverter-defibrillator. J Am Coll Cardiol 1994, 24:416-424.
107. Swerdlow CD, Chen PS, Kass RM, et al. Discrimination of ventricular tachycardia from sinus tachycardia and atrial fibrillation in a tiered-therapy cardioverter-defibrillator. J Am Coll Cardiol 1994, 23:1342-1355.
108. Gronefeld GC, Schulte B, Hohnloser SH, et al. Morphology discrimination: A beat-to-beat algorithm for the discrimination of ventricular from supraventricular tachycardia by implantable cardioverter defibrillators. PACE 2001, 24:1519-1524.
109. Boriani G, Biffi M, Frabetti L, et al. Clinical evaluation of morphology discrimination: An algorithm for rhythm discrimination in cardioverter defibrillators. PACE 2001, 24:994-1001.
110. Gold MR, Shorofsky SR, Thompson JA, et al. Advanced rhythm discrimination for implantable cardioverter defibrillators using electrogram vector timing and correlation. J Cardiovasc Electrophysiol 2002, 13:1092-1097.
111. TM morphology discrimination algorithm in a worldwide single chamber ICD population [abstract]. Circulation 2003, 110:III-345.
112. Stadler RW, Gunderson BD, Gillberg JM An adaptive interval-based algorithm for withholding ICD therapy during sinus tachycardia. PACE 2003, 26:1189-1201.
113. Stein KM, Euler DE, Mehra R, et al. Do atrial tachyarrhythmias beget ventricular tachyarrhythmias in defibrillator recipients?. J Am Coll Cardiol 2002, 40:335-340.
114. Aliot E, Nitzsche R, Ripart A Arrhythmia detection by dual-chamber implantable cardioverter defibrillators: A review of current algorithms. Europace 2004, 6:273-286.
115. Wilkoff B, Sterns L, Morgan JM, et al. Preventing shocks after ICD implantation: Can a strategy of standardized ICD programming match physician tailored?. Heart Rhythm 2005, 2:1034.
116. Deisenhofer I, Kolb C, Ndrepepa G, et al. Do current dual chamber cardioverter defibrillators have advantages over conventional single chamber cardioverter defibrillators in reducing inappropriate therapies? A randomized, prospective study. J Cardiovasc Electrophysiol 2001, 12:134-142.
117. Theuns DA, Klootwijk AP, Goedhart DM, et al. Prevention of inappropriate therapy in implantable cardioverter-defibrillators: Results of a prospective, randomized study of tachyarrhythmia detection algorithms. J Am Coll Cardiol 2004, 44:2362-2367.
118. Bansch D, Steffgen F, Gronefeld G, et al. The 1+1 trial: A prospective trial of a dual- versus a single-chamber implantable defibrillator in patients with slow ventricular tachycardias. Circulation 2004, 110:1022-1029.
119. Friedman PA, McClelland RL, Bamlet WR, et al. Dual chamber versus single chamber detection enhancements for implantable defibrillator rhythm diagnosis: The detect supraventricular tachycardia study. Circulation 2006, 113:2871-2879.
120. Wathen MS, Volosin KJ, Sweeney MO, et al. Ventricular anti-tachycardia pacing by implantable cardioverter defibrillators reduces shocks for inappropriately detected supraventricular tachycardia [abstract]. Heart Rhythm 2004, 1:S148.
121. Knight BP, Zivin A, Souza J, et al. A technique for the rapid diagnosis of atrial tachycardia in the electrophysiology laboratory. J Am Coll Cardiol 1999, 33:775-781.
122. Paz O, Birgersdotter-Green U, Swerdlow C Acceleration of ventricular rate following atrial antitachycardia pacing: What is the mechanism?. J Cardiovasc Electrophysiol 2003, 14:1382-1384.
123. Zeger SL, Liang KY, Albert PS Models for longitudinal data: A generalized estimating equation approach. Biometrics 1998, 44:1049-1060.
124. Hall GH The clinical application of Bayes' theorem. Lancet 1967, 2:555-557.
125. Malik M Pitfalls of the concept of incremental specificity used in comparisons of dual chamber VT/VF detection algorithms. PACE 2000, 23:1166-1170.
126. Olson W, Gunderson BD, Fang-Yen M, et al. Properties and peformance of rate detection algorithms in three implantable cardioverter defibrillators. Comput Cardiol 1994, 65-68.
127. Birgersdotter-Green U, Rosenqvist M, Lindemans FW, et al. Holter documented sudden death in a patient with an implanted defibrillator. PACE 1991, 15:1008-1014.
128. Schwartzman D, Musley SK, Swerdlow C, et al. Early recurrence of atrial fibrillation after ambulatory shock conversion. J Am Coll Cardiol 2002, 40:93-99.
129. Schaumann A, von zur Muhlen F, Herse B, et al. Empirical versus tested antitachycardia pacing in implantable cardioverter defibrillators: A prospective study including 200 patients. Circulation 1998, 97:66-74.
130. Wathen MS, Sweeney MO, DeGroot PJ, et al. Shock reduction using antitachycardia pacing for spontaneous rapid ventricular tachycardia in patients with coronary artery disease. Circulation 2001, 104:796-801.
131. Wathen MS, DeGroot PJ, Sweeney MO, et al. Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators: Pacing Fast Ventricular Tachycardia Reduces Shock Therapies (PainFREE Rx II) trial results. Circulation 2004, 110:2591-2596.
132. Bardy GH, Lee KL, Mark DB, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005, 352:225-237.
133. Gunderson BD, Gillberg JM, Olson WH, et al. Effect of programmed number of intervals to detect ventricular fibrillation on implantable cardioverter defibrillator longevity and unnecessary shocks [abstract]. Circulation 2002, 106:322.
134. Aminoff MJ, Scheinman MM, Griffin JC, et al. Electrocerebral accompaniments of syncope associated with malignant ventricular arrhythmias. Ann Intern Med 1988, 108:791-796.
135. Daubert JP, Wojciech Z, Cannom DC, et al. Frequency and mechanisms of inappropriate ICD therapy in MADIT II [abstract]. J Am Coll Cardiol 2004, 43:132A.
136. Kouakam C, Kacet S, Hazard JR, et al. Performance of a dual-chamber implantable defibrillator algorithm for discrimination of ventricular from supraventricular tachycardia. Europace 2004, 6:32-42.
137. Frang P, Kus T, Vinet A, et al. Underdetection of ventricular tachycardia using 40 ms stability criterion: Effect of antiar-rhythmic thearpy. PACE 1997, 20:2882-2892.
138. Morgan JM, Sterns LD, Hanson JL, et al. A trial design for evaluation of empiric programming of implantable cardioverter defibrillators to improve patient management. Curr Control Trials Cardiovasc Med 2004, 5:12.
139. Panotopoulos P, Krum D, Axtell K, et al. Ventricular fibrillation sensing and detection by implantable defibrillators: Is one better than the others? A prospective, comparative study. J Cardiovasc Electrophysiol 2001, 12:445-452.
140. Kolb C, Deisenhofer I, Weyerbrock S, et al. Incidence of antitachycardia therapy suspension due to magnet reversion in implantable cardioverter defibrillators. PACE 2004, 27:221-223.
141. Bansch D, Castrucci M, Bocker D, et al. Ventricular tachycardias above the initially programmed tachycardia detection interval in patients with implantable cardioverter-defibrillators: Incidence, prediction and significance. J Am Coll Cardiol 2000, 36:557-565.
142. Shukla HH, Flaker GC, Jayam V, et al. High defibrillation thresholds in trans venous biphasic implantable defibrillators: Clinical predictors and prognostic implications. PACE 2003, 26(1 Pt 1):44-48.
143. Brode SE, Schwartzman D, Callans DJ, et al. ICD-antiarrhythmic drug and ICD-pacemaker interactions. J Cardiovasc Electrophysiol 1997, 8:830-842.
144. Monahan KM, Hadjis T, Hallett N, et al. Relation of induced to spontaneous ventricular tachycardia from analysis of stored far-field implantable defibrillator electrograms. Am J Cardiol 1999, 83:349-353.
145. Weber M, Bocker D, Bansch D, et al. Efficacy and safety of the initial use of stability and onset criteria in implantable cardioverter defibrillators. J Cardiovasc Electrophysiol 1999, 10:145-153.
146. Cohen AI, Wish MH, Fletcher RD, et al. The use and interaction of permanent pacemakers and the automatic implantable cardioverter defibrillator. PACE 1988, 11(6 Pt 1):704-711.
147. Geiger MJ, O'Neill P, Sharma A, et al. Interactions between transvenous nonthoracotomy cardioverter defibrillator systems and permanent transvenous endocardial pacemakers. PACE 1997, 20(3 Pt 1):624-630.
148. Glikson M, Trusty JM, Grice SK, et al. A stepwise testing protocol for modern implantable cardioverter-defibrillator systems to prevent pacemaker-implantable cardioverter-defibrillator interactions. Am J Cardiol 1999, 83:360-366.
149. Wietholt D, Kuehlkamp V, Meisel E, et al. Prevention of sustained ventricular tachyarrhythmias in patients with implantable cardioverter-defibrillators: The PREVENT study. J Interv Card Electrophysiol 2003, 9:383-389.
150. Shalaby AA Delayed detection of ventricular tachycardia in a dual chamber rate adaptive pacing implantable cardioverter defibrillator: A case of intradevice interaction. PACE 2004, 27:1164-1166. 2004.
151. Pascal D, Hazard J, Besson B, et al. Contribution of pacemaker stored electrograms to patient management [abstract]. PACE 2000, 23(Part II):681.
152. Seidl K, Meisel E, VanAgt E, et al. Is the atrial high rate episode diagnostic feature reliable in detecting paroxysmal episodes of atrial tachyarrhythmias?. PACE 1998, 21(4 Pt 1):694-700.
153. Morris MM, KenKnight BH, Lang DJ Detection of atrial arrhythmia for cardiac rhythm management by implantable devices. J Electrocardiol 2000, 33(Suppl):133-139.
154. Schuchert A, Boriani G, Wollmann C, et al. Implantable dual-chamber defibrillator for the selective treatment of spontaneous atrial and ventricular arrhythmias: Arrhythmia incidence and device performance. J Interv Card Electrophysiol 2005, 12:149-156.
155. Krahn AD, Klein GJ, Yee R, et al. Maturation of the sensed electrogram amplitude over time in a new subcutaneous implantable loop recorder. PACE 1997, 20:1686-1690.
156. Chrysostomakis SI, Klapsinos NC, Simantirakis EN, et al. Sensing issues related to the clinical use of implantable loop recorders. Europace 2003, 5:143-148.
157. Mazur A, Wang L, Anderson ME, et al. Functional similarity between electrograms recorded from an implantable cardioverter defibrillator emulator and the surface electrocardiogram. PACE 2001, 24:34-40.
158. Bardy G, Cappato R, Smith WM, et al. The totally subcutaneous ICD system (the S-ICD) [abstract]. PACE 2002, 25:222.
159. Bardy G Subcutaneous implantable defibrillator. Dynamic Electrocardiography 2004, Futura, Armonk, NY. M. Malik (Ed.).
160. Bordachar P, Garrigue S, Reuter S, et al. Hemodynamic assessment of right, left, and biventricular pacing by peak endocardial acceleration and echocardiography in patients with end-stage heart failure. PACE 2000, 23(11 Pt 2):1726-1730.
161. Hegbom F, Hoff PI, Oie B, et al. RV function in stable and unstable VT: Is there a need for hemodynamic monitoring in future defibrillators?. PACE 2001, 24:172-182.
162. Kaye G, Astridge P, Perrins J Tachycardia recognition and diagnosis from changes in right atrial pressure waveform: A feasibility study. PACE 1991, 14:1384-1392.
163. Khoury D, McAlister H, Wilkoff B, et al. Continuous right ventricular volume assessment by catheter measurement of impedance for antitachycardia system control. PACE 1989, 12:1918-1926.
164. Sharma AD, Bennett TD, Erickson M, et al. Right ventricular pressure during ventricular arrhythmias in humans: Potential implications for implantable antitachycardia devices. J Am Coll Cardiol 1990, 15:648-655.
165. Wood M, Ellenbogen KA, Lu B, et al. A prospective study of right ventricular pulse pressure and dP/dt to discriminant-induced ventricular tachycardia from supraventricular and sinus tachycardia in man. PACE 1990, 13:1148-1157.
166. Ellenbogen KA, Lu B, Kapadia K, et al. Usefulness of right ventricular pulse pressure as a potential sensor for hemodynamically unstable ventricular tachycardia. Am J Cardiol 1990, 65:1105-1111.
167. Plicchi G, Marcelli E, Marini S An endocardial acceleration sensor for sustained ventricular tachycardia detection [abstract]. Europace Suppl 2002, 3:96.
168. Whitman T, Sheldon T, McFadden S Endocardial acceleration measurements in tachycardia induced heart failure in canines [abstract]. PACE 2002, 24:569.
169. Nabutovsky Y, Pavek T, Wright G, Turcott R Chronic performance of a subcutaneous photoplethysmography sensor [abstract]. Heart Rhythm 2004, 1:476.
170. Turcott R Detection of hemodynamically unstable arrhythmias using subcutaneous photoplethysmography [abstract]. Heart Rhythm 2005, 2:S83.
171. Bennett T, Kjellstrom B, Taepke R, et al. Development of implantable devices for continuous ambulatory monitoring of central hemodynamic values in heart failure patients. PACE 2005, 28:573-584.
172. Cleland JG, Coletta AP, Freemantle N, et al. Clinical trials update from the American College of Cardiology meeting: CARE-HF and the Remission of Heart Failure, Women's Health Study, TNT, COMPASS-HF, VERITAS, CANPAP, PEECH and PREMIER. Eur J Heart Fail 2005, 7:931-936.
173. Kay G Troubleshooting and programming of cardiac resyn-chronization therapy. Device Therapy for Congestive Heart Failure 2004, 232-293. Elsevier, Philadelphia. K.A. Ellenbogen, G. Kay, B. Wilkoff (Eds.).
174. Swerdlow C, Friedman P Advanced ICD troubleshooting: Part II. PACE 2006, 29:70-96.
175. Meyer Y Wavelets: Algorithms and Applications 1993, Society for
176. Morris M, Marcovecchio A, KenKnight B, et al. Retrospective evaluation of detection enhancements in a dual-chamber implantable cardioverter defibrillator: Implications for device programming [abstract]. PACE 1999, 22(4 Part II):849.
177. Willems R, Morck ML, Exner DV, et al. Ventricular high-rate episodes in pacemaker diagnostics identify a high-risk subgroup of patients with tachy-brady syndrome. Heart Rhythm 2004, 1:414-421.
178. Swerdlow CD, Schsls W, Dijkman B, et al. Detection of atrial fibrillation and flutter by a dual-chamber implantable cardioverter-defibrillator. For the Worldwide Jewel AF Investigators. Circulation 2000, 101:878-885.
179. Swerdlow CD, Schwartzman D, Hoyt R, et al. Determinants of first-shock success for atrial implantable cardioverter defibrillators. J Cardiovasc Electrophysiol 2002, 13:347-354.